You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 8.1% | 14.7% |
| ROCE | 19.6% |
| Latest | Forecast | |
|---|---|---|
| P/E | 36.9 | 17.8 |
| PEG | 0.0 | 0.3 |
| Price / Revenue | 3.1 | 2.5 |
| Price / Book value | 5.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 26.1% | 24.4% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 65.8% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | 30.18 | 2.07 | 9.50p | 17.8 | 0.1 | 296% | n/a | 0.0% |
| 2016-12-31 | 39.23 | -0.22 | 6.80p | 22.4 | -0.8 | -28% | n/a | 0.0% |
| 2017-12-31 | 47.62 | -4.45 | 4.20p | 43.7 | -1.1 | -38% | n/a | 0.0% |
| 2018-12-31 | 54.11 | -10.77 | -20.00p | -7.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 68.25 | 4.99 | 12.00p | 32.8 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 84.54 | 12.46 | 21.85p | 17.8 | 0.2 | 82% | 0.00p | 0.0% |
| 2021-12-31 | 97.49 | 14.73 | 24.95p | 15.6 | 1.1 | 14% | 0.00p | 0.0% |
| Ergomed to check drug safety for US Covid-19 trial Sharecast News | 30 Mar |
|---|---|
| Ergomed earnings rise as it begins Covid therapy testing Sharecast News | 25 Mar |
| Ergomed confirms involvement in Italian Covid-19 study Sharecast News | 18 Mar |
| Total Voting Rights | 01-Apr-20 07:05 |
|---|---|
| Holding(s) in Company | 30-Mar-20 16:37 |
| Second Price Monitoring Extn | 25-Mar-20 16:43 |
| Price Monitoring Extension | 25-Mar-20 16:38 |
| Audited full year results | 25-Mar-20 07:06 |